Primary Recipient

EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.

Amount

$5,351,252.00

Award Date

9/30/2009

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

Advance the development of the next generation anthrax vaccine, dmPA7909, to meet the nation's needs for an anthrax vaccine which will facilitate the following: 1. Rapid Immune response following 2-3 doses 2. Long-term stability to facilitate ambient tem